Company Overview

​Renexxion, Inc. is a US based biotechnology company with a wholly owned Irish subsidiary; Renexxion Ireland Limited.

​We are committed to delivering innovative drugs to patients with a high unmet need in gastrointestinal disorders with its pipeline in a pill: Naronapride.

For more information on Naronapride visit: https://www.rnexltd.ie/ ​ 

                         News

For the latest press releases, visit: https://www.rnexltd.ie/press.html​

                 Contact

Address: 1 First Street, Suite #7, Los Altos, CA 94022
Phone:     1.650.980.8966 

Founders

Our leadership team is composed of biotech industry veterans with many years of experience ​in all areas of pharmaceutical drug development, management and financing.

Peter G. Milner

MD, FACC
​Co-Founder and Director​

MORE

Pascal Druzgala

PhD
​Co-Founder and Director​

MORE

Ken Kengatharan

PhD, MBA
​Co-Founder and Director

MORE

Naronapride: Pipeline in a Pill

Learn about Renexxion's innovation with Naronapride.

Learn about
​Naronapride

Knowledge Center

Learn more about gastrointestinal (GI) conditions.

Knowledge Center

Partnerships

Innovation with our strategic partners. 

Dr. Falk Pharma

Get in touch with us.


Address: 1 First Street, Suite #7, Los Altos, CA 94022
Phone: 1.650.980.8966 


​